Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy

This study has been terminated.

(Based on preliminary safety data.)

Sponsor:

Information provided by (Responsible Party):

Acceleron Pharma, Inc.

ClinicalTrials.gov Identifier:

NCT01099761

First received: April 2, 2010

Last updated: January 31, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2011
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	January 24, 2013